Bone Health Assessment and Management among Survivors of Non-metastatic Breast Cancer: A Narrative Review
Abstrak
Breast cancer, the most common hormone responsive cancer, is on a rise both globally and in India. With increased longevity of breast cancer survivors, addressing long-term complications such as osteoporosis is crucial. Several mechanisms contribute to the bone loss seen in breast cancer patients, including age, post-menopausal status, chemotherapy, and other adjuvant therapies received. Appropriate evaluation and counselling on the risks of therapy with aromatase inhibitors on bone health are much needed. Timely initiation of anti-resorptive medication can help improve bone mass, reduce the incidence of fractures, and improve quality of life.
Topik & Kata Kunci
Penulis (6)
Rebecca John
Kripa E. Cherian
Patricia Sebastian
Rajesh Balakrishnan
Selvamani Backianathan
Thomas V. Paul
Akses Cepat
- Tahun Terbit
- 2025
- Sumber Database
- DOAJ
- DOI
- 10.4103/ijem.ijem_94_25
- Akses
- Open Access ✓